AstraZeneca Tops Earnings Views And Shares Rise Despite Cancer Miss

investors.com/news/technology/astrazeneca-stock-astrazeneca-earnings-q1-2025-branch

AstraZeneca stock rose moderately Tuesday despite a mixed first-quarter report and a setback for its experimental prostate cancer treatment.
The post AstraZeneca Tops Earnings Views And Shares Rise Despite Cancer Miss appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-04-29 16:22:39.
The Entire Business World on a Single Page. Free to Use →